Communication
Organic & Biomolecular Chemistry
J. D. Loike, Chemistry and pharmacology of natural pro-
ducts. Lignans: chemical, biological and clinical properties,
Cambridge University Press, Cambridge, 1990.
Table 3 Scope of the aryne substrate for the synthesis of 3-methylene-
3,4-dihydro-2H-pyrrolesb
2 (a) E. G. Brown, Ring Nitrogen and Key Biomolecules: The
Biochemistry of N-heterocycles, Kluwer Academic, Boston,
1998; (b) Comprehensive Heterocyclic Chemistry III, ed.
A. R. Katritzky, C. A. Ramsden, E. F. V. Scriven and
R. J. K. Taylor, Pergamon, Oxford, U. K., 2008, vol. 1–13;
(c) K. C. Majumdar, G. V. Karunakar and B. Sinha,
Synthesis, 2012, 2475; (d) Z. Ye, L. Shi, X. Shao, X. Xu, Z. Xu
and Z. Li, J. Agric. Food Chem., 2013, 61, 312; (e) E. J. Kang
and E. Lee, Chem. Rev., 2005, 105, 4348; (f) A. Bermejo,
B. Figadere, M.-C. Zafra-Polo, I. Barrachina, E. Estornell
and D. Cortes, Nat. Prod. Rep., 2005, 22, 269; (g) J. W. Daly,
T. F. Spande and H. M. Garraffo, J. Nat. Prod., 2005, 68,
1556.
3 (a) Refer to the special “Insight” on plant defence in
Nature, 2001, 411, 825; (b) L. Malet-Sanz and F. Susanne,
J. Med. Chem., 2012, 55, 4062; (c) A. Thomas, Angew. Chem.,
Int. Ed., 2010, 49, 8328.
4 (a) D. C. Robacker, A. B. Demilo and D. J. Voaden, J. Chem.
Ecol., 1997, 23, 1263 and references cited therein;
(b) A. Adams and N. D. Kimpe, Chem. Rev., 2006, 106, 2299;
(c) D. Tsukamoto, M. Shibano, R. Okamoto and G. Kusano,
Chem. Pharm. Bull., 2001, 49, 492; (d) S. Tyroller,
W. Zwickenpflug and E. Richter, J. Agric. Food Chem., 2002,
50, 4909; (e) D. Urosevic, S. Schann, J.-D. Ehrhardt,
P. Bousquet and H. Greney, Br. J. Pharmacol., 2004, 142,
609.
a Inseparable mixtures of m-Me and p-Me isomers in a 1 : 1 ratio for
each pair of 3l : 3l′ and 3m : 3m′ were formed. b Reaction conditions:
1a/1d/1i (0.4 mmol), 2b/2c (0.4 mmol), CsF (1.2 mmol), CH3CN
(3 mL); AuClPEt3/AgSbF6 (10/15 mol%); yields are for isolated
products. All of the reactions were carried out under a nitrogen
atmosphere.
5 (a) E. Tsujii, M. Muroi, N. Shiragami and A. Takatsuki,
Biochem. Biophys. Res. Commun., 1996, 220, 459; (b) S. Schann,
V. Bruban, K. Pompermayer, J. Feldman, B. Pfeiffer,
P. Renard, E. Scalbert, P. Bousquet and J.-D. Ehrhardt,
J. Med. Chem., 2001, 44, 1588; (c) J.-B. Behr, M. S. M. Pearson,
C. Bello, P. Vogel and R. Plantier-Royon, Tetrahedron: Asym-
metry, 2008, 19, 1829; (d) M. Hadden and P. J. Stevenson,
Tetrahedron Lett., 1999, 40, 1215; (e) C. A. Leach, T. H. Brown,
R. J. Ife, D. J. Keeling, S. M. Laing, M. E. Parsons,
C. A. Price and K. J. Wiggall, J. Med. Chem., 1992, 35, 1845.
6 For a review, see: (a) G. Dannhardt and W. Kiefer, Arch. Pharm.
Pharm. Med. Chem., 2001, 334, 183; (b) M.-G. A. Shvekhgeimer,
Chemistry of Heterocyclic Compounds, Plenum Publishing
Corporation, New York, 2003, vol. 39, no. 4, pp. 405–448.
7 (a) T. Burgemeister, G. Dannhardt, M. Mach-Bindl and
H. Nöth, Chemiker-Zeitung, 1988, 112, 93; (b) T. Burgemeister,
G. Dannhardt, M. Mach-Bindl and H. Nöth, Arch. Pharm.,
1988, 321, 349.
Current research is focused on further exploitation of the reac-
tivity of the substituted β-enaminone derivatives.
Acknowledgements
We thank CSIR-IICT for providing a start-up grant, the Depart-
ment of Science and Technology (DST) India for a Fast track
grant, and CSIR, New Delhi for financial support as part of XII
Five Year plan under title ORIGIN (CSC-0108). We also thank
Dr GS for his support. KG thanks CSIR, NSVMRM thanks UGC
for Junior Research Fellowship and also gives thanks to AcSIR.
Notes and references
1 (a) T. Eicher and S. Hauptmann, The Chemistry of Hetero-
cycles: Structure, Reactions, Syntheses, and Applications,
Wiley-VCH, Weinheim, Germany, 2003; (b) Comprehensive
Heterocyclic Chemistry II, ed. A. R. Katritzky, C. W. Rees and
E. F. V. Scriven, Pergamon, Oxford, U. K., 1996, vol. 1–9;
(c) M. Saleem, H. J. Kim, M. S. Ali and Y. S. Lee, Nat. Prod.
Rep., 2005, 22, 696; (d) E. J. Kang and E. Lee, Chem. Rev.,
2005, 105, 4348; (e) G. M. Cragg and D. J. Newman,
8 (a) S. A. Laufer, J. Augustin, G. Dannhardt and W. Kiefer,
J. Med. Chem., 1994, 37, 1894; (b) S. Laufer, S. Tries,
J. Augustin and G. Dannhardt, Arzneim.-Forsch./Drug Res.,
1994, 44, 629.
9 K. R. Scott, G. O. Rankin, J. P. Stables, M. S. Alexander,
I. O. Edafiogho, V. A. Farrar, K. R. Kolen, J. A. Moore,
L. D. Sims and A. D. Tonnu, J. Med. Chem., 1995, 38,
4033.
Expert Opin. Invest. Drugs, 2000, 9, 2783; (f) D. Ayres and 10 G. Dannhardt and A. Bauer, Pharmazie, 1996, 51, 805.
2872 | Org. Biomol. Chem., 2014, 12, 2869–2873
This journal is © The Royal Society of Chemistry 2014